Stacey Johnson
Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.
Posts by: Stacey
Right Turn: Signals’ Top 10 most popular blogs of 2022
Last week bloggers Cal Strode and Tannen Horber shared their favourite blogs from the past year, and I wondered whether there would be any overlap in the Top 10 list below where the number of readers for each post dictates who makes the cut. The answer is “yes.” One of Cal’s favourites was the post […]
Right Turn: Favourite blog posts of 2022
Having written several “my favourite blog posts” over the years, I decided to turn this very important responsibility over to my communications colleagues at CCRM. I asked Cal Strode and Tannen Horber, who are both contributors and have bios on the site, to pick their favourite posts and explain their choices. Cal Strode’s top Signals […]
Right Turn: Lupus’ moment
Back in 2014, Selena Gomez was diagnosed with lupus. The singer and actress has been public about getting chemotherapy to treat her condition, and her kidney transplant. The autoimmune disease causes the immune system to attack the body’s tissues and organs. Inflammation caused by lupus can affect joints, skin, kidneys, blood cells, the brain, heart […]
Right Turn: Phacilitate’s Advanced Therapies Week 2023 offers “reasons to be cheerful”
Last year saw the organizers behind Advanced Therapies Week (ATW) move the conference from Miami to Miami Beach to accommodate a larger audience. As the Covid-19 pandemic was still going strong in January 2022, making international travel more difficult, attendance was lower than anticipated. In fact, on-site testing resulted in some delegates being turned away […]